Profiles and Reports

Continued scientific and technological innovations are critical to fostering sustained economic growth, global competitiveness, and most importantly, helping patients live longer, healthier, and more productive lives. The U.S. innovative biopharmaceutical industry is committed to building on new scientific discoveries and technological advances, relying on a workforce with education and skills in science, technology, engineering, and math (STEM).

Selected Facts About Alzheimer's Disease

Alzheimer’s Disease/Dementia

  • Today, 5.3 million people are living with Alzheimer’s—every 70 seconds, someone develops the disease.
  • Some 5.1 million people with Alzheimer’s are age 65 and older, but an estimated 500,000 people younger than age 65 either have Alzheimer’s or another dementia.
  • Alzheimer’s disease is the most common type of dementia, accounting for 60 percent to 80 percent of cases. 

What We Learn From Clinical Trials

04.04.13 | By

A recent op-ed in Forbes offers a welcome rebuttal to misguided criticism of the conduct of clinical trials by the biopharmaceutical industry by refuting the notion that "medicine is broken" partly due to the hiding of "negative" clinical trial results.

Development of Biopharmaceuticals

04.01.13 | By

Today, we are pleased to have a guest blog post on incremental innovation from Eric A. Utt, Ph.D., Director, Worldwide Policy for Pfizer.

Over 8,200 Clinical Trials of Medicines Conducted by Texas Research Institutions Since 1999

WASHINGTON, D.C.

Medicines in Development

Each patient battling with a disease or managing a condition lives in the hope that tomorrow will bring a new medicine that delivers better health. America’s biopharmaceutical research companies share the same goal of developing new medicines that can prevent diseases, improve patients’ health, and save lives. Beyond each individual patient, new drugs can help society overall by reducing sick days and helping cut the cost of healthcare.

Innovation Hub

Medical innovation from America’s biopharmaceutical research companies continues to help patients live longer, healthier, and more productive lives. Most of us are familiar with the landmark innovations that have defined our health care landscape. What few of us understand, however, are the processes and complexities that lead to biopharmaceutical advances, or the many moving parts and contributors that make progress possible.

Research in Your Backyard

There’s a good chance you can find a clinical trial taking place practically in your own backyard. Biopharmaceutical companies are conducting clinical trials of new medicines in collaboration with clinical research centers, university medical schools and hospitals all across the country. These trials provide patients with access to new potential therapeutic options.

Intellectual Property

Innovation

Innovation—it is what everyone likes to talk about, but what does it really mean for millions of patients battling disease? Simply put, medical innovation can help patients live longer, healthier and more productive lives.

Pages

Subscribe to RSS - Innovation